References
- Moran AE, Holzapfel KL, Xing Y et al. T cell receptor signal strength
in Treg and iNKT cell development demonstrated by a novel fluorescent
reporter mouse. J Exp Med 2011; 208:1279-89.
- Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of
CD4+CD25+ regulatory T cells
induced by an agonist self-peptide. Nat Immunol 2001; 2:301-6.
- Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of
developing thymocytes induces Foxp3 expression and regulatory T cell
differentiation independently of interleukin 2. Nat Immunol 2005;
6:152-62.
- Nazzal D, Gradolatto A, Truffault F et al. Human thymus medullary
epithelial cells promote regulatory T-cell generation by stimulating
interleukin-2 production via ICOS ligand. Cell Death Dis 2014;
5:e1420.
- Watanabe N, Wang YH, Lee HK et al. Hassall’s corpuscles instruct
dendritic cells to induce
CD4+CD25+ regulatory T cells in
human thymus. Nature 2005; 436:1181-5.
- Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and
function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-6.
- Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new
forkhead/winged-helix protein, scurfin, results in the fatal
lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;
27:68-73.
- Gavin MA, Rasmussen JP, Fontenot JD et al. Foxp3-dependent programme
of regulatory T-cell differentiation. Nature 2007; 445:771-5.
- Lin W, Haribhai D, Relland LM, et al. Regulatory T cell development in
the absence of functional Foxp3. Nat Immunol 2007; 8:359-68.
- Wan YY, Flavell RA. Regulatory T-cell functions are subverted and
converted owing to attenuated Foxp3 expression. Nature 2007;
445:766-70.
- Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, Bellucci R,
Raderschall E, Canning C, Soiffer RJ, Frank DA, Ritz J. IL-2 regulates
FOXP3 expression in human CD4+CD25+ regulatory T cells through a
STAT-dependent mechanism and induces the expansion of these cells in
vivo. Blood. 2006 Sep 1;108(5):1571-9.
- Tone Y, Furuuchi K, Kojima Y et al. Smad3 and NFAT cooperate to induce
Foxp3 expression through its enhancer. Nat Immunol 2008; 9:194-202.
- Burchill MA, Yang J, Vogtenhuber C et al. IL-2 receptor beta-dependent
STAT5 activation is required for the development of
Foxp3+ regulatory T cells. J Immunol 2007;
178:280-90.
- Feske S, Müller JM, Graf D et al. Severe combined immunodeficiency due
to defective binding of the nuclear factor of activated T cells in T
lymphocytes of two male siblings. Eur J Immunol 1996; 26:2119-26.
- Sauer S, Bruno L, Hertweck A et al T cell receptor signaling controls
Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A
2008; 105:7797-802.
- Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25-
naive T cells to CD4+CD25+regulatory T cells by TGF-beta induction of transcription factor
Foxp3. J Exp Med 2003; 198:1875-86.
- Horwitz DA, Zheng SG, Wang J, Gray JD. Critical role of IL-2 and
TGF-beta in generation, function and stabilization of
Foxp3+CD4+ Treg. Eur J Immunol
2008; 38:912-5.
- Semple K, Nguyen A, Yu Y et al. Strong CD28 costimulation suppresses
induction of regulatory T cells from naive precursors through Lck
signaling. Blood 2011; 117:3096-103.
- Gottschalk RA, Corse E, Allison JP. TCR ligand density and affinity
determine peripheral induction of Foxp3 in vivo. J Exp Med 2010 Aug
2;207(8):1701-11.
- Kretschmer K, Apostolou I, Hawiger D et al. Inducing and expanding
regulatory T cell populations by foreign antigen. Nat Immunol 2005;
6:1219-27.
- Zeng H, Zhang R, Jin B, Chen L. Type 1 regulatory T cells: a new
mechanism of peripheral immune tolerance. Cell Mol Immunol 2015;
12:566-71.
- Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell
subset inhibits antigen-specific T-cell responses and prevents
colitis. Nature 1997; 389:737-42.
- Gagliani N, Magnani CF, Huber S et al. Co-expression of CD49b and
LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med
2013; 19:739-46.
- Jin JO, Han X, Yu Q. Interleukin-6 induces the generation of
IL-10-producing Tr1 cells and suppresses autoimmune tissue
inflammation. J Autoimmun 2013; 40:28-44.
- Pot C, Jin H, Awasthi A et al. Cutting edge: IL-27 induces the
transcription factor c-Maf cytokine IL-21, and the costimulatory
receptor ICOS that coordinately act together to promote
differentiation of IL-10-producing Tr1 cells. J Immunol 2009;
183:797-801.
- Levings MK, Gregori S, Tresoldi E et al. Differentiation of Tr1 cells
by immature dendritic cells requires IL-10 but not
CD25+CD4+ Tr cells. Blood 2005;
105:1162-9.
- Yang Y, Ochando J, Yopp A et al. IL-6 plays a unique role in
initiating c-Maf expression during early stage of CD4 T cell
activation. J Immunol 2005;174:2720-9.
- Wang H, Meng R, Li Z et al. IL-27 induces the differentiation of
Tr1-like cells from human naive CD4+ T cells via the
phosphorylation of STAT1 and STAT3. Immunol Lett 2011; 136:21-8.
- Hashemi V, Farrokhi AS, Tanomand A et al. Polymorphism of Foxp3 gene
affects the frequency of regulatory T cells and disease activity in
patients with rheumatoid arthritis in Iranian population. Immunol Lett
2018; 204:16-22.
- Rossetti M, Spreafico R, Consolaro A et al. TCR repertoire sequencing
identifies synovial Treg cell clonotypes in the bloodstream during
active inflammation in human arthritis. Ann Rheum Dis 2017;
76:435-441.
- Zare HR, Habibagahi M, Vahdati A, Habibagahi Z. Patients with Active
Rheumatoid Arthritis Have Lower Frequency of nTregs in Peripheral
Blood. Iran J Immunol 2015; 12:166-75.
- Beavis PA, Gregory B, Green P et al. Resistance to regulatory T
cell-mediated suppression in rheumatoid arthritis can be bypassed by
ectopic Foxp3 expression in pathogenic synovial T cells. Proc Natl
Acad Sci U S A 2011; 108:16717-22.
- Haas J, Hug A, Viehöver A et al. Reduced suppressive effect of
CD4+CD25high regulatory T cells on the T cell immune response against
myelin oligodendrocyte glycoprotein in patients with multiple
sclerosis. Eur J Immunol 2005; 35:3343-52.
- Azimi M, Ghabaee M, Moghadasi AN et al. Immunomodulatory function of
Treg-derived exosomes is impaired in patients with relapsing-remitting
multiple sclerosis. Immunol Res 2018; 66:513-520.
- Kimura K, Hohjoh H, Fukuoka M et al. Circulating exosomes suppress the
induction of regulatory T cells via let-7i in multiple sclerosis. Nat
Commun 2018; 9:17.
- Venken K, Hellings N, Broekmans T et al. Natural naive
CD4+CD25+CD127lowregulatory T cell (Treg) development and function are disturbed in
multiple sclerosis patients: recovery of memory Treg homeostasis
during disease progression. J Immunol 2008; 180:6411-20.
- Sambucci M, Gargano F, De Rosa V et al. FoxP3 isoforms and PD-1
expression by T regulatory cells in multiple sclerosis. Sci Rep 2018;
8:3674.
- Kato R, Sumitomo S, Tsuchida Y et al.
CD4+CD25+LAG3+ T
cells with a feature of Th17 cells associated with systemic lupus
erythematosus disease activity. Front Immunol 2019; 10:1619.
- Jin X, Zhang C, Gong L, Li H, Wang Y, Li Q, Li H. Altered expression
of CD39 on memory regulatory T cells in type 1 diabetes patients. J
Diabetes 2019; 11:440-448.
- Scherm MG, Serr I, Zahm AM et al. miRNA142-3p targets Tet2 and impairs
Treg differentiation and stability in models of type 1 diabetes. Nat
Commun 2019; 10:5697.
- Hope CM, Welch J, Mohandas A et al. Peptidase inhibitor 16 identifies
a human regulatory T-cell subset with reduced FOXP3 expression over
the first year of recent onset type 1 diabetes. Eur J Immunol 2019;
49:1235-250.
- Kurup SP, Obeng-Adjei N, Anthony SM et al. Regulatory T cells impede
acute and long-term immunity to blood-stage malaria through CTLA-4.
Nat Med 2017; 23:1220-225.
- Boyle MJ, Jagannathan P, Farrington LA et al. Decline of
FoxP3+ Regulatory CD4 T cells in peripheral blood of
children heavily exposed to malaria. PLoS Pathog 2015; 11:e1005041.
- Tillu H, Tripathy AS, Reshmi PV, Cecilia D. Altered profile of
regulatory T cells and associated cytokines in mild and moderate
dengue. Eur J Clin Microbiol Infect Dis 2016; 35:453-61.
- Jayaratne HE, Wijeratne D, Fernando S et al. Regulatory T-cells in
acute dengue viral infection. Immunology 2018; 154:89-97.
- Roider J, Ngoepe A, Muenchhoff M, et al. Increased regulatory T-cell
activity and enhanced T-cell homeostatic signaling in slow progressing
HIV-infected children. Front Immunol. 2019; 10:213.
- Eggena MP, Barugahare B, Jones N et al. Depletion of regulatory T
cells in HIV infection is associated with immune activation. J Immunol
2005;174:4407-14.
- Chase AJ, Yang HC, Zhang H et al. Preservation of
FoxP3+ regulatory T cells in the peripheral blood of
human immunodeficiency virus type 1-infected elite suppressors
correlates with low CD4+ T-cell activation. J Virol
2008; 82: 8307-15.
- Xiao J, Zhang L, Dong Y et al. PD-1 Upregulation is associated with
exhaustion of regulatory T cells and reflects immune activation in
HIV-1-infected individuals. AIDS Res Hum Retroviruses 2019;
35:444-452.
- Younes SA, Talla A, Pereira Ribeiro S et al. Cycling
CD4+ T cells in HIV-infected immune non-responders
have mitochondrial dysfunction. J Clin Invest 2018; 128:5083-94.
- Whibley N, Maccallum DM, Vickers MA et al. Expansion of
Foxp3+ T-cell populations by Candida albicansenhances both Th17-cell responses and fungal dissemination after
intravenous challenge. Eur J Immunol 2014; 44:1069-83.
- Pandiyan P, Conti HR, Zheng L et al.
CD4+CD25+Foxp3+regulatory T cells promote Th17 cells in vitro and enhance host
resistance in mouse Candida albicans Th17 cell infection model.
Immunity 2011; 34:422-34.
- Kumar P, Misra P, Thakur CP et al. T cell suppression in the bone
marrow of visceral leishmaniasis patients: impact of parasite load.
Clin Exp Immunol 2018; 191:318-327.
- Bhattacharya P, Ghosh S, Ejazi SA et al. Induction of IL-10 and TGFβ
from
CD4+CD25+FoxP3+T cells correlates with parasite load in Indian kala-azar patients
infected with Leishmania donovani . PLoS Negl Trop Dis. 2016;
10:e0004422.
- Guyot-Revol V, Innes JA, Hackforth S et al. Regulatory T cells are
expanded in blood and disease sites in patients with tuberculosis. Am
J Respir Crit Care Med 2006; 173: 803-10.
- Ribeiro-Rodrigues R, Resende Co T, Rojas R et al. A role for
CD4+CD25+ T cells in regulation of
the immune response during human tuberculosis. Clin Exp Immunol 2006;
144:25-34.
- Chen X, Zhou B, Li M et al.
CD4+CD25+FoxP3+regulatory T cells suppress Mycobacterium tuberculosis immunity in
patients with active disease. Clin Immunol 2007; 123:50-9.
- Li L, Lao SH, Wu CY. Increased frequency of
CD4+CD25high Treg cells inhibit
BCG-specific induction of IFN-gamma by CD4+ T cells
from TB patients. Tuberculosis (Edinb) 2007; 87:526-34.
- Ghazalsofala R, Rezaee SA, Rafatpanah H et al. Evaluation of
CD4+CD25+ FoxP3+Regulatory T cells and FoxP3 and CTLA-4 gene expression in patients
with newly diagnosed tuberculosis in northeast of Iran. Jundishapur J
Microbiol 2015; 8:e17726.
- Zewdie M, Howe R, Hoff ST et al. Ex-vivo characterization of
regulatory T cells in pulmonary tuberculosis patients, latently
infected persons, and healthy endemic controls. Tuberculosis (Edinb)
2016; 100:61-68.
- Ahmed A, Adiga V, Nayak S et al. Circulating HLA-DR+CD4+ effector
memory T cells resistant to CCR5 and PD-L1 mediated suppression
compromise regulatory T cell function in tuberculosis. PLoS Pathog
2018; 14: e1007289.
- Ihantola EL, Viisanen T, Gazali AM et al. Effector T Cell resistance
to suppression and STAT3 signaling during the development of human
type 1 diabetes. J Immunol 2018; 201:1144-153.
- Lawson JM, Tremble J, Dayan C et al. Increased resistance to
CD4+CD25hi regulatory T
cell-mediated suppression in patients with type 1 diabetes. Clin Exp
Immunol 2008; 154:353-59.
- Schneider A, Rieck M, Sanda S et al. The effector T cells of diabetic
subjects are resistant to regulation via
CD4+FOXP3+ regulatory T cells. J
Immunol 2008; 181:7350-355.
- Basdeo SA, Moran B, Cluxton D et al. Polyfunctional, Pathogenic CD161+
Th17 lineage cells are resistant to regulatory t cell-mediated
suppression in the context of autoimmunity. J Immunol 2015;
195:528-40.
- Thorborn GS, Pomeroy L, Ishohanni H et al. Elevated effector cell
sensitivity to Treg-cell suppression that is not associated with
reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects
from progressors. Eur J Immunol. 2012; 42:138-46.
- Elahi S, Dinges WL, Lejarcegui N, Laing KJ, Collier AC, Koelle DM,
McElrath MJ, Horton H. Protective HIV-specific CD8+ T cells evade Treg
cell suppression. Nat Med. 2011 Jul 17;17(8):989-95.
- Ahmed A, Rakshit S, Vyakarnam A. HIV-TB co-infection: mechanisms that
drive reactivation of Mycobacterium tuberculosis in HIV infection.
Oral Dis. 2016; 22 Suppl 1:53-60.
- Queval CJ, Brosch R, Simeone R. The Macrophage: A disputed fortress in
the battle against Mycobacterium tuberculosis . Front Microbiol.
2017; 8:2284.
- Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis.
Nat Rev Immunol 2012; 12:352-66.
- Shafiani S, Dinh C, Ertelt JM, et al. Pathogen-specific Treg cells
expand early during Mycobacterium tuberculosis infection but
are later eliminated in response to Interleukin-12. Immunity 2013;
38:1261-70.
- Shafiani S, Tucker-Heard G, Kariyone A et al. Pathogen-specific
regulatory T cells delay the arrival of effector T cells in the lung
during early tuberculosis. J Exp Med 2010; 207:1409-20.
- Scott-Browne JP, Shafiani S, Tucker-Heard G et al. Expansion and
function of Foxp3-expressing T regulatory cells during tuberculosis. J
Exp Med 2007; 204:2159-69.
- Quinn KM, McHugh RS, Rich FJ et al. Inactivation of
CD4+CD25+ regulatory T cells
during early mycobacterial infection increases cytokine production but
does not affect pathogen load. Immunol Cell Biol 2006; 84:467-74.
- Ozeki Y, Sugawara I, Udagawa T et al. Transient role of
CD4+CD25+ regulatory T cells in
mycobacterial infection in mice. Int Immunol 2010; 22:179-89.
- Kursar M, Koch M, Mittrücker HW et al. Cutting Edge: Regulatory T
cells prevent efficient clearance of Mycobacterium tuberculosis. J
Immunol 2007; 178:2661-5.
- Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley
C,Basaraba RJ, Orme IM. The hypervirulent Mycobacterium tuberculosis
strain HN878induces a potent TH1 response followed by rapid
down-regulation. J Immunol. 2007 Jul 1;179(1):522-31.
- Cardona P, Marzo-Escartín E, Tapia G et al. Oral administration of
heat-killed Mycobacterium manresensis delay progression toward
active tuberculosis in C3HeB/FeJ mice. Front Microbiol 2016; 6:1482.
- Kapina MA, Rubakova EI, Majorov KB et al. Capacity of lung stroma to
educate dendritic cells inhibiting mycobacteria-specific T-cell
response depends upon genetic susceptibility to tuberculosis. PLoS One
2013; 8:e72773.
- Green AM, Mattila JT, Bigbee CL et al. CD4+regulatory T cells in a cynomolgus macaque model ofMycobacterium tuberculosis infection. J Infect Dis 2010;
202:533-41.
- Chen CY, Huang D, Yao S et al. IL-2 simultaneously expands Foxp3+ T
regulatory and T effector cells and confers resistance to severe
tuberculosis (TB): implicative Treg-T effector cooperation in immunity
to TB. J Immunol 2012; 188:4278-88.
- Semple PL, Binder AB, Davids M et al. Regulatory T cells attenuate
mycobacterial stasis in alveolar and blood-derived macrophages from
patients with tuberculosis. Am J Respir Crit Care Med. 2013;187:
1249-58.
- Hougardy JM, Verscheure V, Locht C, Mascart F. In vitro expansion of
CD4+CD25highFOXP3+CD127low/-
regulatory T cells from peripheral blood lymphocytes of healthyMycobacterium tuberculosis -infected humans. Microbes Infect
2007; 9:1325-32.
- Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during
active tuberculosis is characterized by decreased interferon- gamma
production and CD25 expression with elevated forkhead box P3,
transforming growth factor- beta, and interleukin-4 mRNA levels. J
Infect Dis 2007; 195:870-8.
- Davids M, Pooran AS, Pietersen E et al. Regulatory T cells subvert
mycobacterial containment in patients failing extensively
drug-resistant tuberculosis treatment. Am J Respir Crit Care Med 2018;
198:104-116.
- Riou C, Berkowitz N, Goliath R et al. Analysis of the Phenotype of
Mycobacterium tuberculosis-specific CD4+ T cells to
discriminate latent from active tuberculosis in HIV-uninfected and
HIV-infected individuals. Front Immunol 2017; 8:968.
- Adekambi T, Ibegbu CC, Cagle S et al. Biomarkers on patient T cells
diagnose active tuberculosis and monitor treatment response. J Clin
Invest 2015; 125:1827-38.
- Venigalla RK, Tretter T, Krienke S. Reduced
CD4+CD25- T cell sensitivity to
the suppressive function of
CD4+CD25highCD127-/lowregulatory T cells in patients with active systemic lupus
erythematosus. Arthritis Rheum 2008; 58:2120-30.
- Bhela S, Kempsell C, Manohar M et al. Nonapoptotic and extracellular
activity of granzyme B mediates resistance to regulatory T cell (Treg)
suppression by
HLA-DR-CD25hiCD127loTregs in multiple sclerosis and in response to IL-6. J Immunol 2015;
194:2180-18
- Kawamoto K, Pahuja A, Nettles A et al. Downregulation of TGF-βRII in T
effector cells leads to increased resistance to TGF-β-mediated
suppression of autoimmune responses in type I diabetes. Autoimmunity
2012; 45:310-9.
- Haufe S, Haug M, Schepp C et al. Impaired suppression of synovial
fluid CD4+CD25- T cells from
patients with juvenile idiopathic arthritis by
CD4+CD25+ Treg cells. Arthritis Rheum 2011;
63:3153-62.
- Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the
establishment of protective pulmonary CD4+ T cell responses after
vaccination and during Mycobacterium tuberculosis challenge. Nat
Immunol 2007; 8:369-77.
- Rosain J, Kong XF, Martinez-Barricarte R et al. Mendelian
susceptibility to mycobacterial disease: 2014-2018 update. Immunol
Cell Biol 2019; 97:360-67.
- Caretto D, Katzman SD, Villarino AV et al. Cutting edge: the Th1
response inhibits the generation of peripheral regulatory T cells. J
Immunol 2010; 184: 30-4.
- Diller ML, Kudchadkar RR, Delman KA et al. Balancing inflammation: the
link between Th17 and regulatory T cells. Mediators Inflamm 2016;
2016:6309219.
- Ye ZJ, Zhou Q, Du RH et al. Imbalance of Th17 cells and regulatory T
cells in tuberculous pleural effusion. Clin Vaccine Immunol 2011;
18:1608-15.
- Day CL, Abrahams DA, Bunjun R et al. PD-1 Expression onMycobacterium tuberculosis -specific CD4 T cells is associated
with bacterial load in human tuberculosis. Front Immunol. 2018;
9:1995.
- Amaral EP, Machado de Salles É, Barbosa Bomfim CC et al. Inhibiting
adenosine receptor signaling promotes accumulation of effector
CD4+ T cells in the lung parenchyma during severe
tuberculosis. J Infect Dis 2019; 219: 964-974.
- Phillips BL, Mehra S, Ahsan MH et al. LAG3 expression in activeMycobacterium tuberculosis infections. Am J Pathol 2015;
185:820-33.
- Gotot J, Gottschalk C, Leopold S et al. Regulatory T cells use
programmed death 1 ligands to directly suppress autoreactive B cells
in vivo. Proc Natl Acad Sci U S A 2012; 109:10468-473.
- Patterson SJ, Pesenacker AM, Wang AY et al. T regulatory cell
chemokine production mediates pathogenic T cell attraction and
suppression. J Clin Invest 2016; 126:1039-351.
- Barchet W, Price JD, Cella M et al. Complement-induced regulatory T
cells suppress T-cell responses but allow for dendritic-cell
maturation. Blood 2006; 107:1497-504.
- Kemper C, Chan AC, Green JM et al. Activation of human
CD4+ cells with CD3 and CD46 induces a T-regulatory
cell 1 phenotype. Nature 2003; 421:388-92.
- Ikeda T, Hirata S, Fukushima S et al. Dual effects of TRAIL in
suppression of autoimmunity: the inhibition of Th1 cells and the
promotion of regulatory T cells. J Immunol 2010; 185:5259-67.
- Yi Z, Lin WW, Stunz LL, Bishop GA. The adaptor TRAF3 restrains the
lineage determination of thymic regulatory T cells by modulating
signaling via the receptor for IL-2. Nat Immunol;15: 866-74.
- Truscott SM, Abate G, Price JD et al. CD46 engagement on human
CD4+ T cells produces T regulatory type 1-like
regulation of antimycobacterial T cell responses. Infect Immun 2010;
78: 5295-306.
- Bryce PJ, Oyoshi MK, Kawamoto S et al. TRAF1 regulates Th2
differentiation, allergic inflammation and nuclear localization of the
Th2 transcription factor, NIP45. Int Immunol 2006; 18:101-11.
- Brunner T, Kasibhatla S, Pinkoski MJ et al. Expression of Fas ligand
in activated T cells is regulated by c-Myc. J Biol Chem 2000;
275:9767-72.
- Zhang XR, Zhang LY, Devadas S et al. Reciprocal expression of TRAIL
and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset
differentiation. Cell Death Differ 2003; 10:203-10.
- Xie J, Wang H. Semaphorin 7A as a potential immune regulator and
promising therapeutic target in rheumatoid arthritis. Arthritis Res
Ther 2017; 19:10.
- Sun X, Yamada H, Shibata K, et al. CD30 ligand/CD30 plays a critical
role in Th17 differentiation in mice. J Immunol 2010; 185:2222-30.
- Bhaumik S, Basu R. Cellular and molecular dynamics of Th17
differentiation and its developmental plasticity in the intestinal
immune response. Front Immunol 2017; 8:254.
- Snook JP, Kim C, Williams MA. TCR signal strength controls the
differentiation of CD4+ effector and memory T cells.
Sci Immunol 2018; 3(25).
- Baecher-Allan C, Viglietta V, Hafler DA. Inhibition of human
CD4+CD25+/high regulatory T cell
function. J Immunol 2002; 169:6210 -7.
- Moguche AO, Musvosvi M, Penn-Nicholson A et al. Antigen availability
shapes T cell differentiation and function during tuberculosis. Cell
Host Microbe 2017; 21:695-706.
- Sakai S, Kauffman KD, Sallin MA et al. CD4 T Cell-derived IFN-γ plays
a minimal role in control of pulmonary mycobacterium tuberculosis
infection and must be actively repressed by PD-1 to prevent lethal
disease. PLoS Pathog 2016; 12:e1005667.
- Lyadova IV, Tsiganov EN, Kapina MA et al. In mice, tuberculosis
progression is associated with intensive inflammatory response and the
accumulation of Gr-1 cells in the lungs. PLoS One 2010; 5:e10469.
- Orme IM, Robinson RT, Cooper AM. The balance between protective and
pathogenic immune responses in the TB-infected lung. Nat Immunol 2015
Jan;16(1):57-63.
- Gideon HP, Phuah J, Myers AJ et al. Variability in tuberculosis
granuloma T cell responses exists, but a balance of pro- and
anti-inflammatory cytokines is associated with sterilization. PLoS
Pathog 2015; 11: e1004603.
- Fletcher HA, Snowden MA, Landry B et al. T-cell activation is an
immune correlate of risk in BCG vaccinated infants. Nat Commun 2016;
7:11290.
- Pandiyan P, Zheng L, Ishihara S et al.
CD4+CD25+Foxp3+regulatory T cells induce cytokine deprivation-mediated apoptosis of
effector CD4+ T cells. Nat Immunol 2007; 8:1353-62.
- Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in
autoimmunity. Curr Opin Immunol 2009; 21:612-8.
- Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat
Rev Immunol 2008; 8:523-32.
- Gondek DC, Lu LF, Quezada SA, et al. Cutting edge: contact-mediated
suppression by CD4+CD25+regulatory cells involves a granzyme B-dependent, perforin-independent
mechanism. J Immunol 2005; 174:1783-86.
- Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural
regulatory T cells preferentially form aggregates on dendritic cells
in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S
A 2008; 105:10113-8.
- Fallarino F, Grohmann U, Hwang KW et al. Modulation of tryptophan
catabolism by regulatory T cells. Nat Immunol 2003; 4:1206-212.
- Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T
cells. Immunity 2004; 21:503-13.
- Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by
CD39 and CD73 expressed on regulatory T cells mediates immune
suppression. J Exp Med 2007; 204: 1257-65.
- Bopp T, Becker C, Klein M et al. Cyclic adenosine monophosphate is a
key component of regulatory T cell-mediated suppression. J Exp Med
2007; 204:1303-310.